574 related articles for article (PubMed ID: 16804317)
1. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
[TBL] [Abstract][Full Text] [Related]
2. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function, cytokine and IGF-IGFBP interactions in cystic fibrosis patients.
Volta C; Street ME; Ziveri MA; Bonelli P; Spaggiari C; Grzincich GL; Bernasconi S
Horm Res; 2005; 63(4):206-10. PubMed ID: 15900107
[TBL] [Abstract][Full Text] [Related]
5. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet.
Street ME; Volta C; Ziveri MA; Zanacca C; Banchini G; Viani I; Rossi M; Virdis R; Bernasconi S
Clin Endocrinol (Oxf); 2008 Jan; 68(1):22-8. PubMed ID: 17681027
[TBL] [Abstract][Full Text] [Related]
6. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
[TBL] [Abstract][Full Text] [Related]
7. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
[TBL] [Abstract][Full Text] [Related]
9. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
11. Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis.
Street ME; Ziveri MA; Spaggiari C; Viani I; Volta C; Grzincich GL; Virdis R; Bernasconi S
Eur J Endocrinol; 2006 Jan; 154(1):47-52. PubMed ID: 16381990
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
13. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.
Rucker D; Ezzat S; Diamandi A; Khosravi J; Hanley DA
Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965
[TBL] [Abstract][Full Text] [Related]
14. The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis.
Street ME; Spaggiari C; Volta C; Ziveri MA; Viani I; Rossi M; Pisi G; Grzincich G; Bernasconi S
Clin Endocrinol (Oxf); 2009 Apr; 70(4):593-8. PubMed ID: 18721194
[TBL] [Abstract][Full Text] [Related]
15. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
17. Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis.
Cobanoglu N; Atasoy H; Ozcelik U; Yalcin E; Dogru D; Kiper N; Gocmen A
Pediatr Pulmonol; 2009 Jul; 44(7):706-12. PubMed ID: 19504563
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
[TBL] [Abstract][Full Text] [Related]
19. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
